英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03696 英矽智能

交易中 02-27 15:53:30

62.350

-0.500

-0.80%

最高63.500	最低60.500	成交量92.26万
今开62.500	昨收62.850	日振幅4.77%
总市值356.41亿	流通市值356.41亿	总股本5.72亿
成交额5,732万	换手率0.16%	流通股本5.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"英矽智能","latestPrice":62.35,"timestamp":1772178806729,"preClose":62.85,"halted":0,"volume":922550,"delay":0,"changeRate":-0.007955449482895784,"floatShares":571622000,"shares":571622000,"eps":-0.238,"marketStatus":"交易中","change":-0.5,"latestTime":"02-27 15:53:30","open":62.5,"high":63.5,"low":60.5,"amount":57319720,"amplitude":0.047733,"askPrice":62.7,"askSize":16500,"bidPrice":62.35,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.624,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772179800000},"marketStatusCode":2,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":62.85,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0.404545,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696","defaultTab":"news","newsList":[{"id":"2614921000","title":"国产泛KRAS新锐！英硅智能提名ISM6166","url":"https://stock-news.laohu8.com/highlight/detail?id=2614921000","media":"药融圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614921000?lang=zh_cn&edition=full","pubTime":"2026-02-27 08:47","pubTimestamp":1772153227,"startTime":"0","endTime":"0","summary":"药融圈获悉：中国上海，2026年2月27日，生成式人工智能驱动的临床阶段生物医药科技公司英硅智能宣布提名ISM6166为临床前候选化合物。ISM6166是一款强效口服泛KRAS抑制剂，其设计和优化过程由英硅智能Chemistry42平台辅助，有望用于包括肺癌、胰腺癌、结直肠癌和胃癌在内的广谱实体瘤治疗。在临床前研究中，ISM6166展现出卓越的抗肿瘤药效。下一步，英硅智能计划加速ISM6166的IND-enabling研究，并独立或与经验丰富的合作伙伴共同推进该项目进入临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227085319a7244a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227085319a7244a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2612237504","title":"港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612237504","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612237504?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:15","pubTimestamp":1771550100,"startTime":"0","endTime":"0","summary":"【重大事项】英硅智能(03696)获纳入恒生综合指数成份股图达通(02665)获纳入恒生综合指数成份股长风药业(02652)获纳入恒生综合指数成份股翰森制药(03692)：甲磺酸阿美替尼片单药治疗于欧盟获批上市拨康视云-B(02592)：CBT-199新药临床试验申请已生效，临床试验被认定为可安全推进石药集团(01093)：GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准石药","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","03696","02652","02665","03692","VT","BK1144","HSCI","BK4585","VXUS","BK1179","BK1141","02498","BK1589","BK4588"],"gpt_icon":0},{"id":"2612923423","title":"英硅智能(03696)获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612923423","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612923423?lang=zh_cn&edition=full","pubTime":"2026-02-20 08:03","pubTimestamp":1771545791,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能(03696)公布，公司已获恒生指数有限公司选择并将被纳入恒生综合指数的成份股，自2026年3月9日起生效。获纳入恒生综合指数成份股后，公司股份预计将符合沪港通及深港通交易的纳入标准。沪港通及深港通是中国香港与中国内地的资本市场投资者之间的股票交易与投资的渠道。董事会认为，获纳入恒生综合指数成份股反映了国际资本市场对公司行业地位、业务表现及价值的高度认可。此举预期将进一步提升公司股票流动性，透过多元化的股东结构扩大投资者基础，并促进公司长远发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCI","03696","BK1141"],"gpt_icon":0},{"id":"2611123515","title":"英硅智能：AI制药的“可控期权资产”与资本最优解｜估值叙事05","url":"https://stock-news.laohu8.com/highlight/detail?id=2611123515","media":"明亮公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611123515?lang=zh_cn&edition=full","pubTime":"2026-02-15 11:42","pubTimestamp":1771126968,"startTime":"0","endTime":"0","summary":"近日，AI制药公司英硅智能在港股上市以来股价连续上涨，引发市场对AI制药赛道价值重估的关注。然而，率先几年进入二级市场的美股AI制药公司已经历多轮深度调整，市值剧烈下跌。轻资产效率赋予了英硅智能充足的财务缓冲期，公司短期内无股权稀释压力，可等待核心管线ISM001-055的关键临床数据读出，或通过持续授权其他早期管线维持运营。当下正值英硅智能核心管线验证的关键窗口期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260215132330a6fd61e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260215132330a6fd61e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1141","BK1574","BK1191","03696"],"gpt_icon":0},{"id":"2611818992","title":"英硅智能02月12日主力净流入422.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611818992","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611818992?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:15","pubTimestamp":1770884116,"startTime":"0","endTime":"0","summary":"02月12日, 英硅智能股价涨0.61%，报收73.65元，成交金额1.1亿元，换手率0.26%，振幅9.02%，量比0.65。英硅智能今日主力资金净流入422.3万元，上一交易日主力净流出76.5万元。该股近5个交易日上涨8.82%，主力资金累计净流出300.2万元；近20日主力资金累计净流入4056.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161556a6f2773b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161556a6f2773b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2611189189","title":"英硅智能创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611189189","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611189189?lang=zh_cn&edition=full","pubTime":"2026-02-12 13:20","pubTimestamp":1770873627,"startTime":"0","endTime":"0","summary":"格隆汇2月12日丨英硅智能(03696.HK)涨6.69%，报78.1000港元，股价创历史新高，总市值446.44亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212132110a49aef13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212132110a49aef13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2610487645","title":"加速全球化布局：英硅智能联手康哲药业、信达生物88.5亿美元出海、复方丹参滴丸美国梦碎","url":"https://stock-news.laohu8.com/highlight/detail?id=2610487645","media":"中国粉体网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610487645?lang=zh_cn&edition=full","pubTime":"2026-02-10 17:29","pubTimestamp":1770715757,"startTime":"0","endTime":"0","summary":"中国粉体网讯1、英硅智能：与康哲药业达成药物研发战略合作2月10日英硅智能发布公告，其已与康哲药业达成药物研发战略合作。这是中国首款、全球第二款进入临床的VAV1分子胶降解剂。根据协议条款，公司将获得3.5亿美元首付款；在达成后续特定里程碑事件后，还有资格获得总额最高约85亿美元的研发、监管及商业化里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210172925a492f653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210172925a492f653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1161","BK1593","SG9999015978.USD","LU2488822045.USD","LU0455707207.USD","IE00BVYPNP33.GBP","SG9999015952.SGD","LU2097828714.EUR","03696","BK1141","LU1969619763.USD","SG9999015986.USD","LU2097828805.USD","IE00BYV24P56.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","BK1589","LU0502904849.HKD","LU2328871848.SGD","BK1583","LU2242644610.SGD","01801","SG9999004220.SGD","SG9999015945.SGD","LU2097828474.EUR","BK1191","00867","LU2097828631.EUR","LU2097828557.USD","IE00BGHQDM52.EUR"],"gpt_icon":1},{"id":"1170483950","title":"港股异动 | 英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1170483950","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170483950?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:02","pubTimestamp":1770688943,"startTime":"0","endTime":"0","summary":"2月10日，$英矽智能(03696)$涨超9%创新高，该公司与$康哲药业(00867)$达成数千万港元多个药物研发项目合作","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7323b9e43cf2c98249ddbdcb6770aa68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","03696","SG9999015952.SGD","IE00BMCWC346.EUR","BK1191","SG9999004220.SGD","LU2488822045.USD","IE00BVYPNQ40.USD","BK4585","SG9999015986.USD","BK4588","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","SG9999015945.SGD","IE00BYV24P56.USD","BK1593"],"gpt_icon":0},{"id":"2610125976","title":"英硅智能创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2610125976","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610125976?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:36","pubTimestamp":1770687364,"startTime":"0","endTime":"0","summary":"格隆汇2月10日丨英硅智能(03696.HK)涨7.89%，报72.4500港元，股价创历史新高，总市值414.14亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210093620a49133a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210093620a49133a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2610768667","title":"英硅智能(03696)与康哲药业达成数千万港元的中枢神经系统及自身免疫疾病领域的多个药物研发项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2610768667","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610768667?lang=zh_cn&edition=full","pubTime":"2026-02-10 08:15","pubTimestamp":1770682532,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能(03696)发布公告，集团已与康哲药业达成药物研发战略合作。透过该合作，双方将在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据该合作的协议条款，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英硅智能有望就每个项目获得最高达数千万港元的研发费用支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7323b9e43cf2c98249ddbdcb6770aa68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","03696","BK1593","LU2488822045.USD","SG9999004220.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","SG9999015945.SGD","BK1191","00867","SG9999015978.USD","BK1141","IE00BMCWC346.EUR","SG9999015952.SGD"],"gpt_icon":0},{"id":"1167568580","title":"英矽智能Cayman Topco——每个项目亦有望获高达数千万港元研发资助","url":"https://stock-news.laohu8.com/highlight/detail?id=1167568580","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167568580?lang=zh_cn&edition=full","pubTime":"2026-02-10 08:02","pubTimestamp":1770681737,"startTime":"0","endTime":"0","summary":"英矽智能（Insilico Medicine）的离岸母公司Cayman Topco，其研发项目同样将获得可观的资金支持。据悉，该公司旗下每一项研发计划，都有望获得高达数千万港元的专项资助，这将为其在人工智能驱动的新药发现领域提供强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"gpt_icon":0},{"id":"1157247881","title":"英矽智能达成战略合作 将围绕中枢神经系统及自身免疫疾病领域展开多项目协作","url":"https://stock-news.laohu8.com/highlight/detail?id=1157247881","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157247881?lang=zh_cn&edition=full","pubTime":"2026-02-10 08:02","pubTimestamp":1770681737,"startTime":"0","endTime":"0","summary":"人工智能驱动的生物技术公司英矽智能宣布，已达成一项广泛的研究合作。该合作将聚焦于中枢神经系统疾病与自身免疫疾病两大治疗领域，旨在利用其专有的人工智能平台，针对多个创新靶点共同发现和开发新型候选药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7323b9e43cf2c98249ddbdcb6770aa68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2610668800","title":"英硅智能02月09日主力净流入665.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610668800","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610668800?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624920,"startTime":"0","endTime":"0","summary":"02月09日, 英硅智能股价涨8.05%，报收67.15元，成交金额2.7亿元，换手率0.72%，振幅14.48%，量比1.88。英硅智能今日主力资金净流入665.5万元，上一交易日主力净流出1185.7万元。该股近5个交易日上涨11.20%，主力资金累计净流入3805.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入95.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161625a6e53585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161625a6e53585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"1122454925","title":"港股异动 | 英矽智能午后涨超10%，MEN2501再获里程碑付款，大摩看好公司在AIDD领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1122454925","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122454925?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:09","pubTimestamp":1770617382,"startTime":"0","endTime":"0","summary":"2月9日，$英矽智能$午后涨超10%，MEN2501再获里程碑付款，大摩看好公司在AIDD领先地位。消息面上，继2025年7月获得逾2340万港元的开发和监管里程碑付款后，英矽智能在双方合作项目MEN2501完成I期临床试验首例患者给药后，再次获得美纳里尼集团就该项目支付的3900万港元里程碑付款。大摩发布研报称，英矽智能是AIDD领域的领先者，在技术验证与应用方面均取得实质性进展。","market":"hk","thumbnail":"https://static.tigerbbs.com/e9352eeb054da879ea3921619a5a8a9c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e9352eeb054da879ea3921619a5a8a9c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU0528227936.USD","LU1162221912.USD","LU1791710582.SGD","IE00BKVL7J92.USD","BK4504","LU2133065610.SGD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU0314104364.USD","LU0795875086.SGD","LU2111349929.HKD","LU0234570918.USD","BK4534","LU0106831901.USD","LU0882574139.USD","LU1668664300.SGD","LU0098860793.USD","LU1791710400.SGD","BK4127","LU0795875169.SGD","LU2028103732.USD","LU1074936037.SGD","BK4588","LU0106261372.USD","LU0557290698.USD","LU2023251221.USD","LU2347655156.SGD","LU1989772840.SGD","LU0006306889.USD","BK4516","LU1244550221.USD","LU0158827948.USD","LU0912757837.SGD","LU1732800096.USD","LU2089283258.USD","LU0267386448.USD","BK4585","03696","LU2357305700.SGD","LU0225283273.USD","LU1720051108.HKD","LU1363072403.SGD","LU0158827781.USD","LU1989772923.USD","LU1720051017.SGD","LU1732799900.SGD","LU0971096721.USD","LU1548497426.USD","LU2271345857.HKD","BK4581","LU2089284900.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"1199741493","title":"英矽智能任命张海乐博士为临床开发副总裁，主攻肿瘤领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1199741493","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199741493?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:01","pubTimestamp":1770382909,"startTime":"0","endTime":"0","summary":"人工智能驱动的生物技术公司英矽智能宣布一项重要人事任命，张海乐博士正式加入公司，担任临床开发副总裁一职，将全面负责肿瘤学领域的临床开发战略与执行。\n张海乐博士在医学领域拥有深厚的学术背景和丰富的行业经验。此次任命将进一步加强英矽智能在肿瘤药物研发方面的领导力，加速其创新疗法从实验室向临床应用的转化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609020536","title":"【券商聚焦】中泰国际：政策继续支持高品质创新药与高端医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2609020536","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609020536?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:40","pubTimestamp":1770338454,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际发布医药行业2月投资策略，生医疗保健指数1月上涨8.6%，跑赢恒生指数1.7个百分点，主因：1)CXO板块多家企业发布盈喜预告，推动股价上涨。3)国家医保局发布政策支持高品质手术机器人获溢价，医疗器械板块中相关个股上涨。该机构指，国家药监局继续支持高品质创新药发展。中国生物制药本身在肝病、自免、呼吸、肿瘤等领域已有丰富布局，本次通过收购将夯实心血管领域的竞争力。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974664","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","HK0000165453.HKD","BK1576","LU0417516738.SGD","BK1515","SG9999002562.SGD","IE00BZ08YT58.USD","BK1610","LU2125910500.SGD","09996","LU0359202008.SGD","02269","BK1574","LU0326950275.SGD","LU0516422366.SGD","LU0708995583.HKD","LU2039709279.SGD","LU1242518857.USD","LU0572944931.SGD","BK1191","LU0516423174.USD","BK1222","SG9999002463.SGD","09997","IE00B0JY6N72.USD","LU0516423091.SGD","LU0043850808.USD","LU0823426480.USD","LU2045819591.USD","159883","LU0456827905.SGD","LU0039217434.USD","LU0052750758.USD","LU0307460666.USD","LU0320764599.SGD","LU0327786744.USD","LU0348825331.USD","03696","159992","IE00BZ08YS42.EUR","02359","LU0348735423.USD","06978","LU0456846285.SGD","LU0516422440.USD","LU0516422952.EUR","LU0181495838.USD","01177","LU0823426308.USD","LU0359201612.USD"],"gpt_icon":0},{"id":"1152225881","title":"英矽智能提名外周限制性NLRP3抑制剂ISM5059为临床前候选药物，用于治疗多种炎症及代谢适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1152225881","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152225881?lang=zh_cn&edition=full","pubTime":"2026-02-05 21:11","pubTimestamp":1770297103,"startTime":"0","endTime":"0","summary":"人工智能驱动的生物技术公司英矽智能宣布，已提名其候选药物ISM5059作为临床前候选化合物。ISM5059是一种具有外周限制性的NLRP3抑制剂，旨在治疗多种炎症和代谢相关疾病。\n该候选药物的提名标志着其在药物研发管线中取得了重要进展。ISM5059通过精准靶向NLRP3炎症小体，有望为相关疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"gpt_icon":0},{"id":"1174600892","title":"英矽智能（03696）发布2026年1月股份变动月报，已发行股份增加至5.71622亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1174600892","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174600892?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:37","pubTimestamp":1770280670,"startTime":"0","endTime":"0","summary":"英矽智能于2026年2月5日公布2026年1月股份变动月报表。报告期为2026年1月1日至2026年1月31日。已发行股份从上月的557,418,500股增加至571,622,000股，增发14,203,500股。该新增股份于2026年1月21日因悉数行使超额配股权而发行。库存股份数量本月无变化，仍为0股。期权及股权激励方面，首次公开发行前的多项股权激励计划合计期末剩余可行使股份期权31,571,462股，仅有部分期权失效24,058股；首次公开发行后的购股权计划保有27,870,925股期权。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":1},{"id":"1176795349","title":"英矽智能获Menarini集团500万美元里程碑付款，核心药物Men2501实现首次人体给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1176795349","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176795349?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:02","pubTimestamp":1770127372,"startTime":"0","endTime":"0","summary":"人工智能驱动的生物技术公司英矽智能宣布，其合作伙伴Menarini集团已向其支付一笔500万美元的里程碑款项。此次付款的触发条件，是双方合作开发的创新药物Men2501成功达成首次人体（FIH）研究的重大进展。\n这一里程碑标志着Men2501的临床开发迈出了关键一步，为后续研究奠定了坚实基础。该成就不仅验证了项目的科学价值，也体现了双方战略合作的高效执行力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"32bc88debe3c17bc57e22a6f6b3dcca5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2608786488","title":"【国海医药 | 英硅智能】与齐鲁制药达成合作，持续验证AI制药能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608786488","media":"国海Healthcare","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608786488?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:16","pubTimestamp":1770106566,"startTime":"0","endTime":"0","summary":"事件：2026年1月27日，英硅智能发布公告：公司与齐鲁制药签署战略合作协议，双方将围绕心血管与代谢类疾病领域，利用英硅智能的Pharma.AI平台进行小分子抑制剂的研发。持续达成研发合作，AI制药能力不断被认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020317010697a4a3c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020317010697a4a3c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696","09939","01477","BK1191","BK1574","BK1161","BK1515","BK1141"],"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":-0.1827},{"period":"1month","weight":0.0354},{"period":"3month","weight":1.6133},{"period":"ytd","weight":0.6922}],"compareEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0275},{"period":"3month","weight":0.0202},{"period":"6month","weight":0.052},{"period":"1year","weight":0.109},{"period":"ytd","weight":0.0293}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"英矽智能是一家主要从事人工智能在制药领域研发的公司。该公司致力于药物发现引擎的研发，并从事联合用药的发现和开发，包括疾病靶点识别、新分子数据生成以及临床试验结果预测。","exchange":"SEHK","name":"英矽智能","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英矽智能,03696,英矽智能股票,英矽智能股票老虎,英矽智能股票老虎国际,英矽智能行情,英矽智能股票行情,英矽智能股价,英矽智能股市,英矽智能股票价格,英矽智能股票交易,英矽智能股票购买,英矽智能股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}